Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters

[1]  D. Marchetti,et al.  Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells , 2004, Clinical & Experimental Metastasis.

[2]  R. Bataille,et al.  Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease. , 2003, Blood.

[3]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[4]  G. Parmigiani,et al.  Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers , 2003, Science.

[5]  Christine A Iacobuzio-Donahue,et al.  Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. , 2003, The American journal of pathology.

[6]  P. Peltomäki.  Role of DNA mismatch repair defects in the pathogenesis of human cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Ugur Sahin,et al.  Computational dissection of tissue contamination for identification of colon cancer‐specific expression profiles , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Y. Banno,et al.  Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10 , 2003, British Journal of Cancer.

[9]  P. Steeg.  Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[10]  J. Padmanabhan,et al.  Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression , 2002, Oncogene.

[11]  B. Iacopetta.  Are there two sides to colorectal cancer? , 2002, International journal of cancer.

[12]  F. Bertucci,et al.  Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. , 2002, The American journal of pathology.

[13]  L. Ellis,et al.  Impact of Insulin-Like Growth Factor Receptor-I Function on Angiogenesis, Growth, and Metastasis of Colon Cancer , 2002, Laboratory Investigation.

[14]  R. L. Baldwin,et al.  Gene expression in epithelial ovarian carcinoma , 2002, Oncogene.

[15]  J. Otte,et al.  Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. , 2002, Genes & development.

[16]  David E. Misek,et al.  Gene-expression profiles predict survival of patients with lung adenocarcinoma , 2002, Nature Medicine.

[17]  F. Sato,et al.  Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon , 2002, Oncogene.

[18]  R. Iozzo,et al.  Decorin suppresses tumor cell-mediated angiogenesis , 2002, Oncogene.

[19]  G. Leikauf,et al.  Microarrays as cancer keys: an array of possibilities. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  R. O'Connor,et al.  RACK1 Is an Insulin-like Growth Factor 1 (IGF-1) Receptor-interacting Protein That Can Regulate IGF-1-mediated Akt Activation and Protection from Cell Death* , 2002, The Journal of Biological Chemistry.

[21]  Yusuke Nakamura,et al.  Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas , 2002, Oncogene.

[22]  Matthias Kretzler,et al.  Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. , 2002, The American journal of pathology.

[23]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[24]  A. Parle‐McDermott,et al.  Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization , 2002, Oncogene.

[25]  E. Devilard,et al.  Gene expression profiling defines molecular subtypes of classical Hodgkin's disease , 2002, Oncogene.

[26]  H. Senn,et al.  Insulin-like growth factors and cancer. , 2002, The Lancet. Oncology.

[27]  E. Devilard,et al.  Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. , 2002, Human molecular genetics.

[28]  Y. Niu,et al.  Potential markers predicting distant metastasis in axillary node‐negative breast carcinoma , 2002, International journal of cancer.

[29]  Alan Cantor,et al.  Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. , 2002, Journal of the National Cancer Institute.

[30]  Weiqun Li,et al.  RACK1, an Insulin-Like Growth Factor I (IGF-I) Receptor-Interacting Protein, Modulates IGF-I-Dependent Integrin Signaling and Promotes Cell Spreading and Contact with Extracellular Matrix , 2002, Molecular and Cellular Biology.

[31]  J. Willis,et al.  Focus on colon cancer. , 2002, Cancer cell.

[32]  F. Tas,et al.  Prognostic Role of nm23 Gene Expression in Patients With Ovarian Cancer , 2002, American journal of clinical oncology.

[33]  H. Wada,et al.  Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer. , 2002, The Annals of thoracic surgery.

[34]  E. Lander,et al.  Gene expression correlates of clinical prostate cancer behavior. , 2002, Cancer cell.

[35]  W. Hohenberger,et al.  Prediction of distant metastases after curative surgery for rectal cancer. , 2002, The Journal of surgical research.

[36]  L. Thiberville,et al.  Inhibition of tumor growth and metastatic spreading by overexpression of inter‐alpha‐trypsin inhibitor family chains , 2002, International journal of cancer.

[37]  Kazuki Nabeshima,et al.  Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. , 2002, Cancer letters.

[38]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[39]  K. Chai,et al.  Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation , 2002, International journal of cancer.

[40]  A. Dursun,et al.  Prognostic implication of nm23‐H1 expression in colorectal carcinomas , 2002, Pathology.

[41]  W. Hohenberger,et al.  DNA microarrays: a new diagnostic tool and its implications in colorectal cancer , 2002, International Journal of Colorectal Disease.

[42]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  F. Bertucci,et al.  Gene expression profiling of cancer by use of DNA arrays: how far from the clinic? , 2001, The Lancet. Oncology.

[45]  Axel Hoos,et al.  Tissue Microarray Profiling of Cancer Specimens and Cell Lines: Opportunities and Limitations , 2001, Laboratory Investigation.

[46]  L. Staudt,et al.  Signatures of the immune response. , 2001, Immunity.

[47]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[48]  K. Furge,et al.  Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. Hirai,et al.  Interaction of MCC2, a novel homologue of MCC tumor suppressor, with PDZ-domain Protein AIE-75. , 2001, Gene.

[50]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. C. Lee,et al.  Reappraisal of the role of NM23‐H1 in colorectal cancers , 2001, Journal of surgical oncology.

[52]  T Hardmeier,et al.  High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. , 2000, The American journal of pathology.

[53]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[54]  E. Kay,et al.  Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome , 2000, The Journal of pathology.

[55]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[56]  U. Mansmann,et al.  Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array , 1999, International journal of cancer.

[57]  F. Bertucci,et al.  Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. , 1999, Human molecular genetics.

[58]  R. Fisher,et al.  Protein markers in colorectal cancer: predictors of liver metastasis. , 1999, Annals of surgery.

[59]  Samuel Granjeaud,et al.  Expression scanning of an array of growth control genes in human tumor cell lines , 1999, Oncogene.

[60]  U. Alon,et al.  Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R S Warren,et al.  Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization , 1999, Genes, chromosomes & cancer.

[62]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Q. S. Wang,et al.  Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis. , 1998, Carcinogenesis.

[64]  P. Neiman,et al.  A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers , 1998, Genes, chromosomes & cancer.

[65]  Bert Vogelstein,et al.  Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.

[66]  K. Hoang-Xuan,et al.  Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites , 1998, Genes, chromosomes & cancer.

[67]  A. Vecchione,et al.  Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpression. , 1997, Cancer letters.

[68]  S. Nishizuka,et al.  ALLELOTYPE OF ADENOMA AND DIFFERENTIATED ADENOCARCINOMA OF THE STOMACH , 1996, The Journal of pathology.

[69]  G. Lindmark,et al.  NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. , 1996, British Journal of Cancer.

[70]  Thomas Ried,et al.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.

[71]  T Skorski,et al.  De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[72]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[73]  Y. Kodera,et al.  Expression of nm23 H‐1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis , 1994, Cancer.

[74]  P. Sismondi,et al.  FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers , 1993, Genes, chromosomes & cancer.

[75]  E. Liu,et al.  Expression of the matrix Gla protein in urogenital malignancies , 1992, International journal of cancer.

[76]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[77]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.